You have 9 free searches left this month | for more free features.

vorinostat

Showing 51 - 75 of 154

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • +6 more
  • Birmingham, Alabama
  • +297 more
Jan 28, 2023

Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage I Small Lymphocytic Lymphoma Trial in Seattle

Completed
  • Chronic Lymphocytic Leukemia
  • +8 more
  • Fludarabine Phosphate
  • +3 more
  • Seattle, Washington
  • +1 more
Feb 14, 2020

Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer Trial in Baltimore (vorinostat, conventional surgery)

Completed
  • Breast Cancer
  • +3 more
  • vorinostat
  • conventional surgery
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Feb 7, 2020

Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Diffuse Intrinsic Pontine Glioma Trial in Australia, Canada, United States

Completed
  • Anaplastic Astrocytoma
  • +3 more
  • 3-Dimensional Conformal Radiation Therapy
  • +3 more
  • Birmingham, Alabama
  • +179 more
Oct 5, 2021

Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Seattle (drug, procedure, radiation, other)

Completed
  • Male Breast Cancer
  • +2 more
  • vorinostat
  • +7 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jan 2, 2020

Advanced Cancers, Lymphoma Trial in Houston (Azacitidine, Vorinostat, Gemcitabine)

Completed
  • Advanced Cancers
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 14, 2020

Breast Cancer, Tumor Metastasis Trial in Baltimore (Vorinostat, Lapatinib)

Terminated
  • Breast Cancer
  • Neoplasm Metastasis
  • Baltimore, Maryland
    University of Maryland Greenebaum Cancer Center
Oct 31, 2019

Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Duarte, South Pasadena (vorinostat, ixabepilone,

Completed
  • Male Breast Cancer
  • +2 more
  • vorinostat
  • +3 more
  • Duarte, California
  • +1 more
Nov 1, 2019

Lymphoma Trial in Houston (Lenalidomide, Vorinostat, Gemcitabine)

Terminated
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 26, 2019

Recurrent Oral Cavity Adenoid Cystic Carcinoma, Recurrent Salivary Gland Carcinoma, Salivary Gland Adenoid Cystic Carcinoma

Completed
  • Recurrent Oral Cavity Adenoid Cystic Carcinoma
  • +11 more
  • Laboratory Biomarker Analysis
  • Vorinostat
  • Duarte, California
  • +11 more
Jul 14, 2020

Locally Advanced NSCLC Trial in Tampa, Philadelphia, Charleston (vorinostat)

Completed
  • Locally Advanced Non-small Cell Lung Cancer
  • vorinostat
  • Tampa, Florida
  • +2 more
Nov 26, 2019

Adult DLBCL, B-Cell Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Seattle (Autologous Hematopoietic Stem Cell

Completed
  • Adult Diffuse Large B-Cell Lymphoma
  • +5 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Mar 3, 2020

Liver Cancer Trial in Richmond (sorafenib tosylate, vorinostat)

Completed
  • Liver Cancer
  • sorafenib tosylate
  • vorinostat
  • Richmond, Virginia
  • +1 more
Aug 16, 2019

Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Seattle (drug, other, procedure, radiation,

Completed
  • Male Breast Cancer
  • +2 more
  • vorinostat
  • +8 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Aug 15, 2019

HIV-1 Infection Trial in Chapel Hill (Vorinostat, AGS-004)

Terminated
  • HIV-1 Infection
  • Vorinostat
  • AGS-004
  • Chapel Hill, North Carolina
    University of North Carolina Hospitals
Oct 2, 2019

Recurrent Aggressive Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Burkitt Lymphoma Trial in Houston

Not yet recruiting
  • Recurrent Aggressive Non-Hodgkin Lymphoma
  • +6 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 6, 2020

Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx Trial in Columbus (drug,

Completed
  • Stage III Squamous Cell Carcinoma of the Oropharynx
  • Stage IV Squamous Cell Carcinoma of the Oropharynx
  • vorinostat
  • +3 more
  • Columbus, Ohio
    The Ohio State University Comprehensive Cancer Center
Jun 3, 2019

Myelodysplastic Syndrome Trial in Minneapolis, Rochester (drug, biological, other)

Completed
  • Myelodysplastic Syndrome
  • Minneapolis, Minnesota
  • +1 more
May 14, 2019

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • vorinostat
  • +2 more
  • Stanford, California
  • +3 more
May 2, 2019

Leukemia, Acute Myeloid Trial in Minneapolis, Milwaukee (Decitabine, Vorinostat, Fludarabine)

Terminated
  • Leukemia, Acute Myeloid
  • Minneapolis, Minnesota
  • +1 more
Jan 22, 2019

Melanoma, Skin Tumors Trial in Amsterdam (Vorinostat)

Unknown status
  • Melanoma
  • Skin Neoplasms
  • Vorinostat
  • Amsterdam, Netherlands
    Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Oct 16, 2018

Aerodigestive Tract Cancer, Lung Cancer, Esophageal Cancer Trial in Lebanon (Vorinostat)

Completed
  • Aerodigestive Tract Cancer
  • +3 more
  • Vorinostat
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Oct 8, 2018

Von Hippel-Lindau Disease Trial run by the NINDS (Vorinostat)

Completed
  • Von Hippel-Lindau Disease
  • Vorinostat
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 13, 2018

Acute Myeloid Leukemia With 11q23-abnormality in Relapse Trial in Stanford (Temozolomide, Vorinostat)

Completed
  • Acute Myeloid Leukemia With 11q23-abnormality in Relapse
  • Stanford, California
    Stanford University Medical Center
Jul 13, 2018

GVHD, Hematologic Tumors, Non-Neoplastic Hematologic and Lymphocytic Disorder Trial in Ann Arbor (Vorinostat, Tacrolimus,

Completed
  • Graft vs Host Disease
  • +2 more
  • Vorinostat
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Jul 13, 2018